Erika Brown
Family · Huntingdon, PANPI 1720677370
Payments from drug & device makers
Across 125 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$572
- AbbVie$551
- Lilly USA, LLC$268
- Pfizer$148
- GSK$132
- Boehringer Ingelheim$114
- plus $675 from 15 others
What the payments were for
- Consulting fees$33814%
- Food & beverage$2,12286%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 36 | $572 |
| AbbVie | 11 | $551 |
| Lilly USA, LLC | 17 | $268 |
| Pfizer | 9 | $148 |
| GSK | 9 | $132 |
| Boehringer Ingelheim | 7 | $114 |
| AstraZeneca | 7 | $112 |
| Exact Sciences | 4 | $81 |
| Astellas Pharma US Inc | 4 | $67 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $64 |
| Johnson & Johnson(2 entities) | 3 | $59 |
| Myriad Women's Health, Inc. | 1 | $49 |
| Sanofi-aventis U.S. LLC | 3 | $48 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Davol Inc. | 1 | $34 |
| Bayer | 2 | $29 |
| W. L. Gore & Associates, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Viatris Specialty LLC | 1 | $19 |
| Merck | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$2,460 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 127 | $90,758 |
| OzempicSemaglutide | 58 | $77,116 |
| TrulicityDulaglutide | 62 | $70,581 |
| EliquisApixaban | 59 | $55,956 |
| MounjaroTirzepatide | 25 | $29,302 |
| JanuviaSitagliptin Phosphate | 26 | $29,095 |
| RybelsusSemaglutide | 27 | $27,876 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $26,696 |
| XareltoRivaroxaban | 25 | $19,351 |
| MyrbetriqMirabegron | 29 | $17,751 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 30 | $13,875 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $7,655 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 41 | $6,290 |
| Atorvastatin Calcium | 375 | $3,627 |
| Potassium Chloride | 100 | $3,328 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $572 | $104,99285 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $268 | $99,88487 claims |
| Boehringer IngelheimJardiance | $114 | $90,758127 claims |
| PfizerEliquis | $148 | $55,95659 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $132 | $40,57166 claims |
| MerckJanuvia | $15 | $29,09526 claims |
| Johnson & JohnsonXarelto | $59 | $19,35125 claims |
| Astellas Pharma US IncMyrbetriq | $67 | $17,75129 claims |
| AbbVieSynthroid | $551 | $1,40816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,717 family providers in Pennsylvania.
Other family in Huntingdon
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.